PDS Biotechnology annual capital expenditures (capex)
2013
2014
2015
2016
2017
2018
2023
2024
2025
PDS Biotechnology Capital Expenditures (CapEx) Growth & History (PDSB)
PDS Biotechnology's capital expenditures (capex) was $0 for fiscal 2025.
View full PDS Biotechnology company overviewPDS Biotechnology annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $0 | −$29,000 | — |
| 2024 | 2024-12-31 | $29,000 | $29,000 | — |
| 2023 | 2023-12-31 | $0 | — | — |
| 2018 | 2018-12-31 | $0 | −$188,721 | — |
| 2017 | 2017-12-31 | $188,721 | −$497,984 | −72.52% |
| 2016 | 2016-12-31 | $686,705 | −$618,381 | −47.38% |
| 2015 | 2015-12-31 | $1.3M | $420,293 | +47.50% |
| 2014 | 2014-12-31 | $884,793 | $747,899 | +546.33% |
| 2013 | 2013-12-31 | $136,894 | — | — |
PDS Biotechnology quarterly capital expenditures (capex)
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q3.23
Q3.24
Q3.25
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q3 2025 | 2025-09-30 | $0 | −$1 | — |
| Q3 2024 | 2024-09-30 | $1 | $1 | — |
| Q3 2023 | 2023-09-30 | $0 | — | — |
| Q4 2018 | 2018-12-31 | $0 | −$27,970 | — |
| Q3 2018 | 2018-09-30 | $0 | −$55,089 | — |
| Q2 2018 | 2018-06-30 | $0 | −$16,378 | — |
| Q1 2018 | 2018-03-31 | $0 | −$89,284 | — |
| Q4 2017 | 2017-12-31 | $27,970 | −$319,325 | −91.95% |
| Q3 2017 | 2017-09-30 | $55,089 | −$89,004 | −61.77% |
| Q2 2017 | 2017-06-30 | $16,378 | −$101,652 | −86.12% |
| Q1 2017 | 2017-03-31 | $89,284 | $11,997 | +15.52% |
| Q4 2016 | 2016-12-31 | $347,295 | −$158,367 | −31.32% |
| Q3 2016 | 2016-09-30 | $144,093 | −$208,161 | −59.09% |
| Q2 2016 | 2016-06-30 | $118,030 | −$243,062 | −67.31% |
| Q1 2016 | 2016-03-31 | $77,287 | −$8,791 | −10.21% |
| Q4 2015 | 2015-12-31 | $505,662 | — | — |
| Q3 2015 | 2015-09-30 | $352,254 | — | — |
| Q2 2015 | 2015-06-30 | $361,092 | — | — |
| Q1 2015 | 2015-03-31 | $86,078 | — | — |
PDS Biotechnology capital expenditures (capex) trends
Between the periods ended 2013-12-31 and 2025-12-31, PDS Biotechnology's capital expenditures (capex) decreased from $136,894 to $0, a change of −$136,894. The latest reported quarter, Q3 2025, shows $0.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review PDS Biotechnology source filings ↗